{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:18:23Z","timestamp":1775744303131,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1016\/s1359-6446(03)02713-2","type":"journal-article","created":{"date-parts":[[2003,6,30]],"date-time":"2003-06-30T12:45:30Z","timestamp":1056977130000},"page":"536-544","source":"Crossref","is-referenced-by-count":534,"title":["Drugs from the deep: marine natural products as drug candidates"],"prefix":"10.1016","volume":"8","author":[{"given":"Burkhard","family":"Haefner","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1359-6446(03)02713-2_BIB1","first-page":"62","article-title":"Marine pharmacology","volume":"42","author":"Mayer","year":"2000","journal-title":"The Pharmacologist"},{"key":"10.1016\/S1359-6446(03)02713-2_BIB2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00253-002-1006-8","article-title":"Drugs from the sea \u2013 current status and microbiological implications","volume":"59","author":"Proksch","year":"2002","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB3","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2174\/1381612003399653","article-title":"Conotoxins \u2013 new vistas for peptide therapeutics","volume":"6","author":"Jones","year":"2000","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB4","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0041-0101(01)00145-3","article-title":"Cone venom \u2013 from accidental stings to deliberate injection","volume":"39","author":"McIntosh","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/S1359-6446(03)02713-2_BIB5","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1517\/13543784.9.10.2403","article-title":"An evaluation of intrathecal Ziconotide for the treatment of chronic pain","volume":"9","author":"Jain","year":"2000","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/S1359-6446(03)02713-2_BIB6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1039\/b009211h","article-title":"The chemistry and biology of the bryostatin antitumour macrolides","volume":"19","author":"Hale","year":"2002","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00001813-200208000-00001","article-title":"The clinical development of the bryostatins","volume":"13","author":"Clamp","year":"2002","journal-title":"Anticancer Drugs"},{"key":"10.1016\/S1359-6446(03)02713-2_BIB8","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1128\/AEM.67.10.4531-4537.2001","article-title":"Evidence for the biosynthesis of bryostatins by the bacterial symbiont \u2018Candidatus Endobugula sertula\u2019 of the bryozoan Bugula neritina","volume":"67","author":"Davidson","year":"2001","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB9","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.1021\/ja990860j","article-title":"Synthesis of bryostatin-2","volume":"121","author":"Evans","year":"1999","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB10","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/1521-3773(20000703)39:13<2290::AID-ANIE2290>3.0.CO;2-6","article-title":"Total synthesis of bryostatin-3","volume":"39","author":"Ohmori","year":"2000","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB11","doi-asserted-by":"crossref","first-page":"7407","DOI":"10.1021\/ja00176a058","article-title":"Synthesis of bryostatin-7","volume":"112","author":"Kageyama","year":"1990","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1074-5521(00)00063-6","article-title":"Inhibition of cyclin-dependent kinases, GSK-3\u03b2 and CK1 by hymenialdisine, a marine sponge constitutent","volume":"7","author":"Meijer","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1021\/jm0102856","article-title":"Aldisine alkaloids from the Philippine sponge Stylissa massa are potent inhibitors of mitogen-activated protein kinase kinase-1 (MEK-1)","volume":"45","author":"Tasdemir","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB14","first-page":"459","article-title":"The natural product hymenialdisine inhibits interleukin-8 production in U937 cells by inhibition of nuclear factor-\u03baB","volume":"282","author":"Breton","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB15","first-page":"955","article-title":"Inhibition of NF-\u03baB-mediated interleukin-1\u03b2-stimulated prostaglandin E2 formation by the marine natural product hymenialdisine","volume":"283","author":"Roshak","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF02684014","article-title":"Scytonemin \u2013 a marine natural product inhibitor of kinases key in hyperproliferative inflammatory disease","volume":"51","author":"Stevenson","year":"2002","journal-title":"Inflamm. Res."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB17","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1124\/jpet.102.036350","article-title":"The identification and characterization of the marine natural product scytonemin as a novel antiproliferative pharmacophore","volume":"303","author":"Stevenson","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0305-0491(90)90194-X","article-title":"Inhibition of intrinsic protein tyrosine kinase activity of EGF-receptor kinase complex from human breast cancer cells by the marine sponge metabolite (+)-aeroplysinin-1","volume":"97","author":"Kreuter","year":"1990","journal-title":"Comp. Biochem. Physiol. B"},{"key":"10.1016\/S1359-6446(03)02713-2_BIB19","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0968-0896(98)00070-4","article-title":"Synthesis and biological evaluation of aeroplysinin analogues: a new class of receptor tyrosine kinase inhibitors","volume":"6","author":"Hinterding","year":"1998","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1096\/fj.01-0427fje","article-title":"Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge","volume":"16","author":"Rodriguez-Nieto","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0006-291X(92)90656-6","article-title":"Marine sponge polyketide inhibitors of protein tyrosine kinase","volume":"184","author":"Lee","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB22","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/bbrc.1994.2176","article-title":"The marine natural product halistanol trisulfate inhibits pp60v-src protein tyrosine kinase activity","volume":"184","author":"Slate","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB23","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1021\/np990010h","article-title":"A new tyrosine kinase inhibitor from the marine brown alga Stypopodium zonale","volume":"62","author":"Wessels","year":"1999","journal-title":"J. Nat. Prod."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB24","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1021\/jo000307g","article-title":"Ascosalipyrrolidinone A, an antimicrobial alkaloid, from the obligate marine fungus Ascochyta salicorniae","volume":"65","author":"Osterhage","year":"2000","journal-title":"J. Org. Chem."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.pharmtox.39.1.175","article-title":"Regulation and inhibition of phospholipase A2","volume":"39","author":"Balsinde","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB26","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2174\/1566524013363258","article-title":"Mammalian secreted phospholipase A2 and their pathophysiological significance in inflammatory diseases","volume":"1","author":"Toqui","year":"2001","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2174\/0929867306666220320223452","article-title":"Manoalide","volume":"6","author":"Soriente","year":"1999","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB28","first-page":"123","article-title":"Variabilin: a dual inhibitor of human secretory and cytosolic phospholipase A2 with antiinflammatroy activity","volume":"282","author":"Escrig","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/sj.bjp.0702302","article-title":"Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2","volume":"126","author":"Garcia-Pastor","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB30","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1021\/np9704922","article-title":"Petrosaspongiolides M-R: new potent and selective phospholipase A2 inhibitors from the New Caledonian marine sponge Petrosaspongia nigra","volume":"61","author":"Randazzo","year":"1998","journal-title":"J. Nat. Prod."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB31","first-page":"166","article-title":"Effects of Petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation","volume":"289","author":"Garcia-Pastor","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB32","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1021\/np000637w","article-title":"New sesquiterpene derivatives from the sponge Dysidea species with a selective inhibitor profile against human phospholipase A2 and other leukocyte functions","volume":"64","author":"Giannini","year":"2001","journal-title":"J. Nat. Prod."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB33","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1021\/np50090a001","article-title":"Phospholipase A2 inhibitors from marine organisms","volume":"55","author":"Potts","year":"1992","journal-title":"J. Nat. Prod."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB34","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1359-6446(01)02038-4","article-title":"Novel molecules that interact with microtubules and have functional activity similar to Taxol\u2122","volume":"6","author":"Lifeng","year":"2001","journal-title":"Drug Discov. Today"},{"key":"10.1016\/S1359-6446(03)02713-2_BIB35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1381612805666230109214008","article-title":"The dolastatins, a family of promising antineoplastic agents","volume":"5","author":"Poncet","year":"1999","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB36","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.2174\/0929867023369051","article-title":"The cyanobacterial origin of potent anticancer agents originally isolated from sea hares","volume":"9","author":"Luesch","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB37","doi-asserted-by":"crossref","first-page":"15882","DOI":"10.1016\/S0021-9258(18)98491-7","article-title":"Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data","volume":"266","author":"Bai","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB38","first-page":"653","article-title":"Laulimalide and isolaulimalide, new paclitaxel-like microtubule-s tabilizing agents","volume":"59","author":"Mooberry","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB39","first-page":"155","article-title":"The novel cytotoxic sponge metabolite peloruside A, structurally similar to bryostatin-1, has unique bioactivity independent of protein kinase C","volume":"16","author":"Hood","year":"2001","journal-title":"Anticancer Drug Des."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB40","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0968-0896(99)00089-9","article-title":"Cytotoxic and tubulin-interactive hemiasterlins from #Auletta# and Siphonochalina spp. sponges","volume":"7","author":"Gamble","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB41","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0006-2952(01)00898-X","article-title":"Inhibition of tubulin polymerisation by vitilevuamide, a bicyclic marine peptide, at a site distinct from colchicine, the vinca alkaloids, and dolastatin-10","volume":"63","author":"Edler","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB42","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1124\/mol.52.4.613","article-title":"The microtubule-stabilzing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits growth of paclitaxel-resitant cell lines","volume":"52","author":"Kowalski","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00129785-200101010-00008","article-title":"DNA: still a target worth aiming at? A Review of new DNA-interactive agents","volume":"1","author":"Anthoney","year":"2001","journal-title":"Am. J. Pharmacogenomics"},{"key":"10.1016\/S1359-6446(03)02713-2_BIB44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1128(200001)20:1<1::AID-MED1>3.0.CO;2-A","article-title":"Antitumor compounds from tunicates","volume":"20","author":"Rinehart","year":"2000","journal-title":"Med. Res. Rev."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB45","first-page":"5267","article-title":"Antitumor activity and nucleic acid binding properties of dercitin, a new acridine alkaloid isolated from marine Dercitus species sponge","volume":"49","author":"Burres","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB46","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0006-2952(91)90031-Y","article-title":"Antitumor activity and biochemical effects of topsentin","volume":"42","author":"Burres","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB47","doi-asserted-by":"crossref","first-page":"9202","DOI":"10.1021\/ja962480t","article-title":"Enantioselective total synthesis of ecteinascidin 743","volume":"118","author":"Corey","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB48","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1021\/ol0062502","article-title":"Synthesis of ecteinascidin ET-743 and phthalascidin PT-650 from cyanosafracin B","volume":"2","author":"Cuevas","year":"2000","journal-title":"Org. Lett."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB49","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S1074-5521(01)00082-5","article-title":"Antitumor activity- and gene expression-based profiling of ecteinascidin Et 743 and phthalascidin Pt 650","volume":"8","author":"Martinez","year":"2001","journal-title":"Chem. Biol."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB50","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00001813-200207000-00001","article-title":"Ecteinascidin 743: a novel anticancer drug with a unique mechanism of action","volume":"13","author":"Aune","year":"2002","journal-title":"Anticancer Drugs"},{"key":"10.1016\/S1359-6446(03)02713-2_BIB51","doi-asserted-by":"crossref","first-page":"6780","DOI":"10.1073\/pnas.97.12.6780","article-title":"Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743","volume":"97","author":"Minuzzo","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB52","first-page":"3377","article-title":"Ecteinascidin-743 inhibits activated but not constitutive transcription","volume":"15","author":"Friedman","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB53","first-page":"1327","article-title":"Overcoming multidrug resistance P-glycoprotein\/MDR1-overexpressing cell lines by ecteinascidin 743","volume":"1","author":"Kanzaki","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB54","first-page":"2908","article-title":"Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: identification of ecteinascidin-743 as a potent cytotoxic agent","volume":"7","author":"Li","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB55","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/91008","article-title":"Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide excision repair","volume":"7","author":"Takebayashi","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB56","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ijc.1221","article-title":"Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA repair pathways","volume":"92","author":"Damia","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S1359-6446(03)02713-2_BIB57","first-page":"3251","article-title":"Sequence-dependent enhancement of cytotoxicity produced by ecteinascidin 743 (ET-743) with doxorubicin or paclitaxel in soft tissue sarcoma cells","volume":"7","author":"Takahashi","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB58","first-page":"1631","article-title":"ET-743 (PharmaMar\/NCI\/Ortho Biotech)","volume":"2","author":"Verschraegen","year":"2001","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/S1359-6446(03)02713-2_BIB59","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1038\/sj.onc.1205972","article-title":"Aplidin\u2122 induces the mitochondrial apoptotic pathway via oxidative stress-mediated JNK and p38 activation and protein kinase C\u03b4","volume":"21","author":"Garcia-Fernandez","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/S1359-6446(03)02713-2_BIB60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1074\/jbc.M201010200","article-title":"Aplidin\u2122 induces apoptosis in human cancer cells via glutathione depletion and sustained activation of the epidermal growth factor receptor, Src, JNK, and p38 MAPK","volume":"278","author":"Cuadrado","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB61","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1021\/jo960877+","article-title":"Kahalalides: bioactive peptides from a marine mollusk Elysia rufescens and its algal diet Bryopsis sp","volume":"61","author":"Hamann","year":"1996","journal-title":"J. Org. Chem."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB62","first-page":"529","article-title":"KRN7000, a novel immunomodulator, and its antitumor activities","volume":"7","author":"Kobayashi","year":"1995","journal-title":"Oncol. Res."},{"issue":"Suppl.","key":"10.1016\/S1359-6446(03)02713-2_BIB63","first-page":"3768S","article-title":"The angiostatic sterol squalamine is a calmodulin chaperone","volume":"5","author":"Chen","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB64","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/jo00028a024","article-title":"Contignasterol, a highly oxygenated steroid with the unnatural 14.beta. configuration from the marine sponge Petrosia contignata Thiele, 1899","volume":"57","author":"Burgoyne","year":"1992","journal-title":"J. Org. Chem."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB65","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1021\/np50108a023","article-title":"Amino acid derivatives from the marine sponge Jaspis digonoxea","volume":"57","author":"Rudi","year":"1994","journal-title":"J. Nat. Prod."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB66","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0165-6147(02)02007-2","article-title":"Functional versus chemical diversity: is biodiversity important for drug discovery?","volume":"23","author":"Tulp","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB67","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0165-6147(02)02099-0","article-title":"Chemical diversity: a function of biodiversity","volume":"23","author":"Cragg","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB68","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0165-6147(02)02100-4","article-title":"Chemical diversity: independent of functional diversity","volume":"23","author":"Tulp","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB69","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/jnci\/91.19.1608","article-title":"A natural edge: nature still offers the greatest drug diversity","volume":"91","author":"Reynolds","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S1359-6446(03)02713-2_BIB70","first-page":"1","article-title":"Oceans: medicine chests of the future?","volume":"13","author":"Rayl","year":"1999","journal-title":"The Scientist"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644603027132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644603027132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T15:42:20Z","timestamp":1682523740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644603027132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":70,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["S1359644603027132"],"URL":"https:\/\/doi.org\/10.1016\/s1359-6446(03)02713-2","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}